Results 31 to 40 of about 3,510,056 (188)

Variation of iStent Procedure Rates by State in Response to the COVID-19 Pandemic

open access: yesClinical Ophthalmology, 2022
Kelly Vogel,1 Cole N Rojas,1 Angelo P Tanna,1 Dustin D French1– 4 1Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; 2Department of Medical Social Science, Northwestern University Feinberg School of ...
Vogel K, Rojas CN, Tanna AP, French DD
doaj  

Evolution of Glaucoma Surgery in the Last 25 Years

open access: yesRambam Maimonides Medical Journal, 2018
Glaucoma is a chronic neurodegenerative optic nerve disease. Treatment is intended to prevent the development and progression of optic nerve damage by lowering intraocular pressure (IOP).
Laura Bar-David, Eytan Z. Blumenthal
doaj   +1 more source

iStent inject trabecular microbypass stent implantation with cataract extraction in open-angle glaucoma: early clinical experience

open access: yesEye and Vision, 2020
Background Retrospective, consecutive case series to evaluate the implantation of two second-generation trabecular microbypass stents in combination with cataract surgery in a real-world, clinical setting.
Tanner J. Ferguson   +6 more
doaj   +1 more source

Minimally Invasive Glaucoma Surgery (MIGS)

open access: yesDelhi Journal of Ophthalmology, 2021
Glaucoma, a chronic progressive optic neuropathy, is the second leading cause of irreversible blindness world-wide. The only treatable risk factor till date is lowering of intra-ocular pressure (IOP), thus, being the mainstay of treatment.
Meena G Menon, Shalini
doaj   +1 more source

Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma. [PDF]

open access: yes, 2012
20.02.14 KB. Ok to add published verson to spiral, OA paper.A pilot study to determine whether topical prostaglandin analogues alter the expression of conjunctival inflammatory markers in patients with uveitic glaucoma.Prospective, single-masked case ...
Sallam, A   +3 more
core   +1 more source

Minimally invasive trabecular meshwork surgery for open-angle glaucoma [PDF]

open access: yes, 2022
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of minimally invasive trabecular meshwork surgery in comparison to medical, laser, or surgical treatment (including other MIGS ...
Bunce, Catey   +21 more
core   +2 more sources

Development of an antifibrotic drug-eluting coating for a minimally invasive implantable glaucoma microstent

open access: yesCurrent Directions in Biomedical Engineering, 2019
Primary open angle glaucoma represents an eye disease that usually is associated with an increased intraocular pressure (IOP). Implants for micro-invasive glaucoma surgery (MIGS) are gaining importance as a promising option for IOP lowering.
Siewert Stefan   +9 more
doaj   +1 more source

Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review

open access: yesEye and Vision, 2019
Trabeculectomy remains the ‘gold standard’ intraocular pressure (IOP)-lowering procedure for moderate-to-severe glaucoma; however, this approach is associated with the need for substantial post-operative management. Micro-invasive glaucoma surgery (MIGS)
Omar Sadruddin   +3 more
doaj   +1 more source

Tactile Feedback for Artery Detection in Minimally Invasive Robotic Surgery –Preliminary Results of a New Approach [PDF]

open access: yes, 2009
Minimally invasive robotic surgery (MIRS) entails total absence of haptic feedback due to the spatial separation of patient and surgeon. In conventional surgery, however, palpation to detect superficial arteries by a slight pulsation is an important,
Hirzinger, Gerd   +13 more
core   +1 more source

Translating Minimally Invasive Glaucoma Surgery Devices [PDF]

open access: yes, 2020
Glaucoma is the leading cause of irreversible blindness with over 70 million people affected worldwide. The surgical management of glaucoma aims to lower intraocular pressure by increasing aqueous outflow facility.
Eames, I   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy